Concepedia
Journal of Thrombosis and Haemostasis · 2004 · 286 citations · 47 references
MedicineHematologyPharmacotherapyHemostasisAnticoagulant TherapyCoagulation DisordersThrombosisThrombosis ManagementThrombosis PreventionThrombotic DisordersBypassing Agent TherapyFactor ViiaRecombinant Activated Factor Vii
47
Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma
U. Martinowitz, Gili Kenet, Eran Segal et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2001 · 449 citations
Medicine, Hematology, Pharmacotherapy +17
Multicenter Retrospective Study on the Utilization of FEIBA in France in Patients with Factor VIII and Factor IX Inhibitors
Claude Négrier, Jenny Goudemand, Sultan Y et al. · Thrombosis and Haemostasis · 1997 · 281 citations
Medicine, Hematology, Surgery +17
Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems
David A. Kessler · JAMA · 1993 · 270 citations
Pharmacy, Pharmaceutical Policy, Drug Approval Processes +16
Adverse drug event monitoring at the food and drug administration
Syed Rizwanuddin Ahmad · Journal of General Internal Medicine · 2003 · 248 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +13
A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United States
Theodore J. Cicero, Edgar H. Adams, Anne Geller et al. · Drug and Alcohol Dependence · 1999 · 242 citations
Pharmacy, Preventive Medicine, Toxicology +16